Concepedia

A Amend

AA

4

Publications

341

Citations

4

H-Index

1995

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

A Amend is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in molecular pharmacology, health sciences, and medicine.

Top concepts

HealthMedicinePhysiologyBiochemistryPharmacologyMetabolic SyndromeMetabolic RegulationMolecular PharmacologyObesityMetabolism

Publications per year

1995–1999

4

Publications

4

Potent and selective human beta(3)-adrenergic receptor antagonists.

Mari R. Candelore, Liping Deng, Laurie Tota et al. · PubMed · 1999 · 125 citations

Selective Beta, Human Adipose Tissue, Selective Human Beta +18

A selective human beta3 adrenergic receptor agonist increases metabolic rate in rhesus monkeys.

M. H. FISHER, A Amend, Tom Bach et al. · Journal of Clinical Investigation · 1998 · 115 citations · Full text

Metabolic Rate, Obesity, Molecular Pharmacology +17

Potent and Selective Human β3-Adrenergic Receptor Antagonists

Mari R. Candelore, Liping Deng, Laurie Tota et al. · Journal of Pharmacology and Experimental Therapeutics · 1999 · 64 citations

Determination of structural domains for G protein coupling and ligand binding in beta 3-adrenergic receptor.

Xiaoming Guan, A Amend, Catherine D. Strader · Molecular Pharmacology · 1995 · 37 citations

Rows per page

1–4 of 4